Image Source: fightfm.com
The Eli Lilly and Co., a drug manufacturing company has withdrawn its application to the Food and Drug Administration of its anti depressant medicine, Cymbalta for approval as chronic pain treatment. The company hopefully intends to re apply the anti depressant drug this coming 2009. The application that Lilly withdrew included information collected from two trials. One from a chromic knee pain for Osteoarthritis and the other trial was in low back pains. Eli Lilly recently filed a new drug application supplement for the Cymbalta to allow them to sell the drug for chronic pain proven in the clinical trials that they took. For the moment, technically, Cymbalta is only FDA approved for treatment of depression, fibromyalgia and diabetic nerve pain.